Right to Choose ADHD in Birmingham

Women and girls across West Midlands are systematically underdiagnosed. ADHD diagnostic criteria were historically developed from studies of hyperactive boys. Women typically present with the inattentive subtype — quiet, internal, masked by socialisation. Many are told it is anxiety, depression, or personality. By the time they reach a GP near Birmingham, they have often been dismissed multiple times.

Right to Choose offers a route to specialist assessment where the clinician understands how ADHD presents in women. But the GP gatekeeping remains. A woman who 'seems fine' in a 10-minute appointment is unlikely to get a referral based on self-report alone. Objective brain data changes this equation entirely. Our qEEG screening measures cortical electrical activity directly — it does not care about socialised masking behaviour. Elevated theta/beta ratio is elevated theta/beta ratio, regardless of how composed you appear in the GP's office.

Our ADHD in women guide covers the hormonal interactions, masking, and diagnostic bias that make this particularly important.

Shared care is the arrangement where a specialist prescribes and stabilises ADHD medication, then transfers ongoing prescribing to your GP. This is how ADHD medication is managed long-term in the UK — the specialist handles initiation and titration, the GP handles repeat prescriptions and monitoring.

Most GPs near Birmingham accept shared care from established Right to Choose providers. The key factors are: the diagnosing clinician is GMC-registered, the assessment meets NICE NG87 standards, the provider is CQC-registered, and the shared care protocol is clear and well-documented. Psychiatry-UK has formal shared care agreements accepted by the vast majority of GP practices.

In the small number of cases where a GP declines shared care, options include: requesting a different GP at the same practice, registering with a different practice, or the diagnosing provider continuing to prescribe privately while you pursue resolution. This is rare but our next steps guide covers it in detail.

The pathway from Birmingham to diagnosis runs through five clear stages. First, evidence gathering: our brain screening provides the objective data, but you should also complete an ASRS-v1.1 (adults) or Conners questionnaire (children), write a functional impairment summary, and gather any historical evidence (school reports, previous assessments).

Second, the GP appointment: book a double slot, present everything in the first minute, and make the Right to Choose request explicitly. Our GP evidence guide has word-for-word scripts. Third, the referral itself: a 5-minute administrative process if the GP has the evidence in front of them. Fourth, the wait: 3–6 months typically, during which you can use the screening report for school, work, and other support. Fifth, the assessment: comprehensive clinical evaluation following NICE NG87, leading to diagnosis and treatment if appropriate.

Most clients near Birmingham complete steps 1–3 within two weeks. The total elapsed time from brain screening to diagnosis is typically 4–8 months — compared to 3–7 years via the standard NHS pathway.

Your screening report serves multiple purposes simultaneously. While you wait for the Right to Choose assessment (3–6 months), the same report can support: EHCP applications for your child's school, JCQ exam access arrangements (extra time, rest breaks), employer reasonable adjustment requests under the Equality Act 2010, Access to Work evidence gathering, and the Right to Choose referral itself. One screening, one report, multiple applications running in parallel.

If you are later diagnosed and prescribed medication, the baseline brain data becomes invaluable. A follow-up medication scan (£345) compares your on-medication brain activity against the baseline — providing objective evidence that treatment is having the intended neurological effect. This data supports medication dosage reviews and shared care monitoring.

A third option is fully private assessment (£700–£1,500), which has the shortest wait (2–8 weeks) but you pay the full cost. Many people from Birmingham combine approaches: brain screening (£595–£845) + Right to Choose assessment (free) + Access to Work support (free). Total out-of-pocket: the screening only. View all pricing options.

We provide Right to Choose evidence for children aged 6+, teenagers, adults, and women & girls who are systematically underdiagnosed by questionnaire-based assessment.

Each person is compared against age-matched normative data from published research. The clinical letter is tailored for Right to Choose referral submissions, with z-scores, peer-reviewed citations, and specific recommendations your GP can act on immediately.

View packages: standard screening (£595) · comprehensive (£845) · family package (£1,095) · all pricing

After your screening: ADHD support hub · results explained · what to do next · GP appointment guide · medication guide · coping strategies · workplace rights · ADHD in women · parent's guide · relationships guide · sleep guide · exercise & ADHD